R. TaylorRipleyMD

Adult General Thoracic Surgery, Minimally Invasive Thoracic Surgery, Thoracic Surgical Oncology

Meyer-DeBakey Chair in Investigative Surgery / Professor / Thoracic Surgeon, Baylor College of Medicine / Director, Mesothelioma Treatment Center / Director, Thoracic Surgical Research / Director, Clinical Trials for Department of Surgery / Editor, Seminars in Thoracic and Cardiovascular Surgery / Vice President, Board of Directors; Mesothelioma Applied Research Foundation

Join to view full profile

Dr. Ripley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ripley's full profile

Already have an account?

Office
7200 Cambridge
Suite 6A
Houston, TX 77030
Phone+1 713-798-6376

Fax+1 713-798-8131

Summary

My primary clinical focus is the on treatment of patients in the Mesothelioma Treatment Center at Baylor College of Medicine. Additionally, I treat patients with all thoracic cancers including lung cancer, esophageal cancer, thymic cancers, and metastatic disease. I utilize robotic surgery to minimize the size of surgical incisions whenever feasible. Also, I focus on chest wall surgery including Slipping Rib Syndrome. Our research laboratory studies tumor metabolism to increase tumor susceptible to therapy.

Vice President, Board of Directors of Meso Foundation. Thoracic Editor, Seminars in Thoracic and Cardiovascular Surgery. Steering Committee, International Association for the Study of Lung Cancer, Mesothelioma Project.
Steering Committee, National Mesothelioma Virtual Database. Member American Association of Thoracic Surgeons.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Thoracic Surgery, 2012 - 2014
University of ColoradoResidency, Surgery, 2004 - 2012
National Cancer Institute2007 - 2010
Vanderbilt University School of MedicineClass of 2004
Boston CollegeBS, Biochemistry, Summa Cum Laude, 2000

Certifications & Licensure

TX State Medical License 2018 - 2026
MD State Medical License 2016 - 2021
NY State Medical License 2012 - 2017
CO State Medical License 2007 - 2013
PA State Medical License 2013 - 2013
DC State Medical License 2009 - 2010
American Board of Surgery Surgery
American Board of Thoracic Surgery Thoracic and Cardiac Surgery

Awards, Honors, & Recognition

Phi Beta Kappa Boston College, 1999
Dean’s Scholar Boston College, 1999
Dan May Scholarship: Basic science research grant Vanderbilt University School of Medicine, 2001
Albert J. McGuinn Award – Bachelor of Science with excellence in humanities and social sciences Boston College, 2000
Join now to see all

Publications & Presentations

PubMed

1058 citations
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
Laura A. Johnson, Richard A. Morgan, Mark E. Dudley, Lydie Cassard, James Chih-Hsin Yang
Blood. 2009-07-16
73 citations
Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells
Mary Zhang, Aarti Mathur, Yuwei Zhang, Sichuan Xi, Scott M. Atay
Cancer Research. 2012-08-15
4 citations
Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus.
Adel Mandl, James Welch, Gayathri Kapoor, Vaishali I. Parekh, David S. Schrump
Endocrine-Related Cancer. 2021-11-01

Books/Book Chapters

TSRA Operative Dictations in Cardiothoracic Surgery
Chapter: Pancoast Tumors.
R. Taylor Ripley, Valerie W. RuschEditors: Odell DO and LaPar DJ.Thoracic Surgery Residents Association, Chicago, ILEdition 1st,2014
Abeloff’s Clinical Oncology
Chapter: Lung metastasis. Chapter 52
Page 764 - 777Ripley RT, Rusch VWElsevier, Philadelphia, PAEdition 5th,2013

Abstracts/Posters

Incidence of Second Primary Lung Cancers in Smokers Versus Non-smokers after Curative Resection of Stage I Lung Adenocarcinoma. (Oral Presentation)
R. Taylor Ripley, MD, Robert R. McMillan, MD MPH, Camelia S. Sima, MD MS, Saad M. Hasan, BA, Feiran Lou, MD, Valerie Rusch, MD, Nabil P. Rizk, MD, James Huang, MD, 50th Annual Meeting of the Society of Thoracic Surgeons, Orlando, FL, 1/1/2014
A Stem Cell Ligand Induced by Cigarette Smoke Enhances the Malignant Phenotype of Lung Cancer Cells.
Robert T. Ripley, Clinton D. Kemp, Aarti Mathur, Julie A. Hong, Mary Zhang, Mahadev Rao, David S. Schrump, 92nd Annual Meeting of the American Association for Thoracic Surgery, Oral Presentation for Lillehei Forum for Resident Research Competition, San Francisco, CA, 4/1/2012
Wnt-5A Modulates Global Gene Expression Profiles and Enhances the Malignant Phenotype of Lung Cancer Cells. (Poster Presentation)
R. Taylor Ripley, Mahadev Rao, Julie A. Hong, Clinton D. Kemp, Aarti Mathur, Mary Zhang, David S. Schrump, The American Association for Cancer Research 101st Annual Meeting, Washington, DC, 4/1/2010
Liver Resection for Metastatic Adrenocortical Carcinoma. (Poster Presentation)
R. Taylor Ripley, M.D., Aarti Mathur, M.D., Clinton D. Kemp, M.D., Richard E. Royal, M.D., Steven K. Libutti, M.D., Seth M. Steinberg, PhD, Bradford J. Wood, M.D., Uda..., The Society of Surgical Oncology 63rd Annual Meeting, St. Louis, MO, 3/1/2010
Liver Resection for Metastatic Melanoma with Postoperative Tumor-Infiltrating Lymphocyte Therapy. (Oral Presentation)
Ripley RT, Davis JL, Klapper JA, Mathur A, Kammula U, Royal RE, Yang JC, Sherry RM, Hughes MS, Libutti SK, White DE, Steinberg SM, Dudley ME, Rosenberg SA, Avital I, The Society of Surgical Oncology 62nd Annual Meeting, Phoenix, AZ, 3/1/2009
Streptococcus milleri infections of the pleural space. (Oral Presentation)
Ripley RT, Cothren CC, Moore EE, Long JS, Johnson JL, Haenel JB, Society of University Surgeons Annual Meeting, San Diego, CA, 2/1/2006
Join now to see all